Health In Tech Announces Voluntary Extension of Lock-Up Period

Rhea-AI Summary

Health In Tech (Nasdaq: HIT) announced on Dec 2, 2025 that its executive officers, vice presidents and board have voluntarily extended their existing lock-up by an additional six months beyond the original twelve-month restriction tied to the company's IPO.

Under the extension, shares held by current executives and directors remain restricted from sale or transfer until June 20, 2026. Health In Tech completed its IPO on Dec 20, 2024, raising gross proceeds of $9.2 million, and says it continues investing in systems, distribution and service expansion.

Positive

• Lock-up extended by 6 months, signaling insider confidence
• Insider shares restricted until June 20, 2026
• Company completed IPO raising $9.2 million in December 2024

Negative

• Insiders have no immediate liquidity until June 20, 2026
• Extended lock-up may limit circulating float in near term

Insights

Corporate governance analyst

Insiders voluntarily extending lock-up reduces near-term selling pressure and signals leadership confidence.

Health In Tech leaders extended insider lock-up six months, keeping executive and board shares restricted until June 20, 2026. This mechanically limits insider liquidity and potential share supply into the market while leadership continues investment in system enhancements and distribution after raising $9.2 million at the IPO.

The action reads as a governance signal rather than an operational change; it depends on continued execution of described initiatives and on whether the extension is voluntary rather than contractually required. The main risk is that the extension merely delays potential selling without addressing business performance; any material operational setbacks before June 20, 2026 would change the practical impact of this signal.

Watch for concrete milestones tied to the stated initiatives—system enhancements, distribution expansion, and service offerings—between now and June 20, 2026, and for disclosures of insider transactions once the restriction lifts. Near-term market supply is constrained, and the extension is most meaningful to assess alongside forthcoming operational updates over the next six months.

STUART, Fla., Dec. 2, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, today announced that its executive management team, vice presidents across functions, and  Board of Directors have voluntarily agreed to extend the lock-up restrictions on all shares they hold for an additional six months beyond the original twelve-month lock-up established at the time of the Company's final prospectus issued in connection with its initial public offering on December 20, 2024.

Under this voluntary extension, all shares held by Health In Tech's current executive officers and Board of Directors will remain restricted from sale or transfer until June 20, 2026.

"Our leadership team remains highly committed to the long-term growth of Health In Tech," said Tim Johnson, CEO of Health In Tech. "By choosing to extend their lock-up period, our executives are demonstrating confidence in the Company's outlook and our ongoing initiatives in technology, underwriting automation, and market expansion."

Health In Tech completed its IPO in December 2024, raising gross proceeds of $9.2 million. The Company has since continued to invest in system enhancements, broaden its distribution network, and expand its service offerings across the self-funded healthcare ecosystem.

Use of Forward‑Looking Statements

Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth strategy and liquidity.

About Health In Tech

Health In Tech (Nasdaq: "HIT") is an Insurtech platform company backed by third-party AI technology, which offers a marketplace that aims to improve processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, and TPAs. Learn more at healthintech.com.

Investor Contact

Investor Relations:
ir@healthintech.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/health-in-tech-announces-voluntary-extension-of-lock-up-period-302629745.html

SOURCE Health In Tech

FAQ

What did Health In Tech (HIT) announce on December 2, 2025?

Health In Tech announced executives, vice presidents and the board voluntarily extended their share lock-up by six months to June 20, 2026.

When does the HIT insider lock-up now expire?

The extended lock-up for insider-held shares expires on June 20, 2026.

How long was the original HIT IPO lock-up and when was the IPO?

The original lock-up was 12 months tied to the IPO completed on December 20, 2024.

How much did Health In Tech raise in its December 2024 IPO (HIT)?

Health In Tech raised gross proceeds of $9.2 million in its December 2024 IPO.

What does the HIT lock-up extension mean for shareholders?

The extension limits insider share sales until June 20, 2026, which may reduce near-term insider selling pressure.